RecruitingPhase 2NCT05470504
Rare condition
Acquired partial lipodystrophy
11
studies recruiting now
as of 7 Sept 2026
26
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
17 Feb 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT05996536
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
RecruitingPhase 3NCT07220785
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
RecruitingNot applicableNCT07412028
Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)
RecruitingPhase 3NCT06679270
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 11 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Acquired partial lipodystrophy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Acquired partial lipodystrophy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (LMNB2).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).